![Robert Booth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Booth
Directeur/Membre du Conseil chez
SUMMIT THERAPEUTICS INC.
Fortune : - $ au 31/05/2026
Profil
Dr. Robert F.
Booth is an Independent Non-Executive Director at Summit Therapeutics, Inc., an Advisor at Prime Movers Lab LLC and an Executive Chairman at Ab Initio Biotherapeutics, Inc. He is on the Board of Directors at Summit Therapeutics, Inc., Acurex Biosciences Corp., Galleon Pharmaceuticals, Inc., Glialogix, Inc. and Thryv Therapeutics, Inc. Dr. Booth was previously employed as an Independent Director by CymaBay Therapeutics, Inc., an Executive Chairman by CuraSen Therapeutics, Inc., an Independent Director by Pharmacyclics LLC, an Operating Partner by TPG Partners LLC, a Chief Executive Officer & Director by Virobay, Inc., a Vice President by Applera Corp., a Chief Scientific Officer by Celera Corp., a Chief Scientific Officer by Celera Genomics Group, a Senior VP-Central Research & Development by Roche Bioscience, a Senior Vice President by Roche Palo Alto LLC, a SVP-Inflammatory & Viral Diseases Business Unit by Hoffmann-La Roche, Inc., a Senior Vice President by Roche Pharmaceuticals, Inc., a Section Head by Searle Research & Development, and a Section Head by Wellcome Research Laboratories.
He received his undergraduate degree from the University of London, a doctorate degree from the University of London and a doctorate degree from St Bartholomew's Hospital Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Robert Booth
| Sociétés | Poste | Début |
|---|---|---|
| SUMMIT THERAPEUTICS INC. | Directeur/Membre du Conseil | 28/09/2022 |
Ab Initio Biotherapeutics, Inc.
 Ab Initio Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company | Fondateur | - |
Thryv Therapeutics, Inc.
 Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapies for the treatment of long qt Syndrome | Directeur/Membre du Conseil | - |
Prime Movers Lab LLC
 Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab invests in companies located in the United States. The firm focuses across a broad range of sectors and industries. It provides financing for early stage transactions. | Consultant / Advisor | - |
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for breathing-control conditions | Directeur/Membre du Conseil | - |
Glialogix, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert Booth
| Sociétés | Poste | Fin |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 24/01/2020 |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Directeur Général | 01/01/2018 |
| TPG INC. | Corporate Officer/Principal | 01/01/2010 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Robert Booth
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Health Technology |
Galleon Pharmaceuticals, Inc.
Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for breathing-control conditions | Health Technology |
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Health Services |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Health Technology |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Discovers and develops medicines | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellcome Research Laboratories | |
Searle Research & Development | |
Roche Bioscience
 Roche Bioscience Pharmaceuticals: MajorHealth Technology Discovers and develops prescription drugs | Health Technology |
St Bartholomew's Hospital Medical College
 St Bartholomew's Hospital Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glialogix, Inc. | |
Ab Initio Biotherapeutics, Inc.
Ab Initio Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company | Health Technology |
Summit Therapeutics, Inc.
 Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Health Technology |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab invests in companies located in the United States. The firm focuses across a broad range of sectors and industries. It provides financing for early stage transactions. | Finance |
Thryv Therapeutics, Inc.
Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapies for the treatment of long qt Syndrome | Health Services |
TPG, Inc.
 TPG, Inc. Investment ManagersFinance Operates as a alternative asset manager | Finance |
